A phase I/II trial of chemoradiotherapy concurrent with S-1 plus mitomycin C in patients with clinical stage II/III squamous cell carcinoma of the anal canal (JCOG0903, SMART-AC)
Latest Information Update: 19 Feb 2019
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Mitomycin
- Indications Anal cancer; Squamous cell cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms SMART-AC
- 19 Jan 2019 Primary endpoint has not been met.
- 19 Jan 2019 Primary endpoint has not been met.
- 19 Jan 2019 Results presented at the 2019 Gastrointestinal Cancers Symposium